Click here to go to the previous page
Enabling Technologies for Cellular Therapy Product Development ISCT/AABB Joint Program
Program Code:
9323-QE-CT
Date:
Monday, October 11, 2010
Time:
2:00 PM to 3:30 PM
EST
DIRECTOR
:
Doug Padley, MT(ASCP), Development Coordinator, Mayo Clinic
MODERATOR
:
Doug Padley, MT(ASCP), Development Coordinator, Mayo Clinic
SPEAKER
(S):
Bruce Levine, PhD, Driector, Clinical Cell and Vaccine Production Facility, University of Pennsylvania
Integrating New Equipment in the Clinical Production of Cellular Therapy Products
Marianna Sabatino
Tim Taga, BSME, MSE, Project Leader, CaridianBCT, Inc.
Product Development Logisitics (CaridianBCT, Inc.)
Description
In this session, three speakers will discuss the development and preclinical life cycle of instrumentation and devices designed for cellular therapy manufacturing. The first speaker will focus on the industry perspective on how the needs of the cell manufacturing community are addressed and incorporated into the final product. The next speaker will describe the process of early preclinical evaluation and testing of the instrumentation. The final speaker will describe the later stages of pre-clinical development and the introduction of new cellular therapy instrumentation into clinical manufacturing.
-
Describe how industry solicits and incorporates the needs of the cellular therapy community in designing new instrumentation for clinical cellular therapy manufacturing.
-
Explore two approaches to identification, evaluation, validation and implementation of new instrumentation used in cellular therapy manufacturing.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.